Fairvalue-Calculator Fairvalue-Calculator
EN DE

PureTech Health plc (PRTCY) Fair Value & Analysis

Healthcare · US · Market cap $422M

Price$17.28
Fair Value$3.38
Upside-80.4%
Quality89/100
Evidence: Low Range $2.23 – $4.23

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

PureTech Health plc (PRTCY) currently trades at $17.28, while our model-based Fair Value estimate is $3.38 — implying the stock looks roughly 80.4% overvalued today. We read business quality at 89/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, a Phase 3-ready therapeutic candidate with the potential to establish a new standard of care (SOC) for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases and LYT-200, a fully human IgG4 monoclonal antibody. The company also develops SPT-300, a Glyphed oral prodrug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development and oral therapies based on defined bacterial consortia that is in phase 3 clinical stage. PureTech Health plc was incorporated in 2015 and is based in Boston, Massachusetts.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -84% Regeneron Pharmaceuticals, Inc (REGN) +109% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -64%

Frequently asked questions

Is PureTech Health plc (PRTCY) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $3.38 versus a price of $17.28 — about −80% (overvalued). Model-based estimate, not financial advice.
What is the fair value of PRTCY?
Our 21-model fair value for PureTech Health plc is $3.38 (as of Jun 25, 2026), built from audited fundamentals. The current price is $17.28.
What is the quality score of PRTCY?
PureTech Health plc has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.